Company Filing History:
Years Active: 2025
Title: Barbara De Klerk-Engels: Innovator in Post Intensive Care Recovery
Introduction
Barbara De Klerk-Engels is a notable inventor based in Ghent, Belgium. She has made significant contributions to the field of healthcare, particularly in the recovery of patients after intensive care unit (ICU) stays. Her innovative approach focuses on the use of collagen hydrolysate to improve recovery and prevent post intensive care syndrome (PICS).
Latest Patents
Barbara holds a patent for her invention titled "Collagen hydrolysate for use in prevention and/or treatment of post intensive care syndrome (PICS)." This patent highlights the use of collagen hydrolysate as a supplement during and after ICU stays. The invention aims to enhance recovery and mitigate the effects of PICS, which can significantly impact patients' quality of life. The safety of collagen hydrolysate makes it a viable option for long-term use.
Career Highlights
Barbara De Klerk-Engels is associated with Rousselot B.V., where she continues to develop her innovative ideas. Her work has garnered attention for its potential to improve patient outcomes in critical care settings. With a focus on practical applications of her research, she has established herself as a key figure in her field.
Collaborations
Some of Barbara's coworkers include Elien Monique Gevaert and Praneeth Reddy Kuninty. Their collaborative efforts contribute to the advancement of research and development in healthcare solutions.
Conclusion
Barbara De Klerk-Engels is a pioneering inventor whose work in collagen hydrolysate has the potential to transform recovery processes for ICU patients. Her dedication to improving healthcare outcomes is evident in her innovative patent and ongoing contributions to the field.